Christian Girard (email@example.com), is the founder of Orphan Drugs industry Advisory & Intelligence, a corporate advisory firm with a focus on alternative financing (dilutive and non-dilutive), business development and orphan drugs companies. Additionally, he is the owner of Orphan Drugs Industry Insider, a competitive intelligence information provider in the rare diseases area.
His entry in life sciences dates back to 1994, when he joined the newly formed French subsidiary of Deknatel, a medtech spin-off of Pfizer, which was later acquired by Genzyme. He is also a co-founder of a biotech company, gmp orphan, repurposing small molecules in orphan indications, as well as an advisor to several US and European research institutions, start-ups and later-stage biopharmas.
He holds a Master of Science in Management from ESCP Europe.